BridgeBio Pharma
BBIO
BBIO
197 hedge funds and large institutions have $2.58B invested in BridgeBio Pharma in 2023 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 70 increasing their positions, 58 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
197
Holders Change
-16
Holders Change %
-7.51%
% of All Funds
3.11%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.11%
New
29
Increased
70
Reduced
58
Closed
44
Calls
$120M
Puts
$93.5M
Net Calls
+$26.3M
Net Calls Change
+$24.6M
Top Buyers
Top Sellers
| 1 |
AIG
American International Group
New York
|
-$29.7M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$18M |
| 3 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$16.9M |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$16.6M |
| 5 |
Renaissance Technologies
New York
|
-$12.7M |
